Surgery News and Research

RSS

Patients with BAI can be managed non-operatively with beta-blockade: Researchers

Select patients with blunt aortic injury can be safely managed non-operatively with beta-blockade to lower the heart rate and blood pressure, according to a new study from the 64th Vascular Annual Meeting presented by the Society for Vascular Surgery.

9 Jun 2010

Researchers compare effectiveness of IB and AMP in high-risk patients

Major amputation is often selected over infrainguinal bypass in patients with severe systemic comorbidities because of a presumed decrease in risk of perioperative morbidity and mortality. To investigate this presumption, researchers from the Division of Vascular and Endovascular Surgery at the Brigham and Women's Hospital in Boston undertook a risk-adjusted comparison of early postoperative morbidity and mortality of high-risk patients undergoing infrainguinal bypass and major amputation.

9 Jun 2010

Tumors not likely to worsen during active surveillance period in low risk prostate cancer patients

Johns Hopkins experts have found that men enrolled in an active surveillance program for prostate cancer that eventually needed surgery to remove their prostates fared just as well as men who opted to remove the gland immediately, except if a follow-up biopsy during surveillance showed high-grade cancer.

9 Jun 2010

Sonic hedgehog helps regenerate critical nerve that runs along prostate: Research

After men have surgery to remove a cancerous prostate gland, up to 80 percent of them will lose the ability to have an erection because of damage to a critical nerve that runs along the prostate.

9 Jun 2010

Preoperative BB usage to help prevent POMI revealed at Vascular Annual Meeting

A regional quality improvement effort aimed at increasing the use of preoperative beta-blocker usage to help prevent postoperative myocardial infarction was revealed today at the 64th Vascular Annual Meeting presented by the Society for Vascular Surgery.

9 Jun 2010

FDA approves City of Hope's neural stem cell-based therapy study for recurrent high-grade gliomas

City of Hope researchers received approval from the U.S. Food and Drug Administration (FDA) to conduct the first-in-human study of a neural stem cell-based therapy targeting recurrent high-grade gliomas, the most aggressive type of brain tumor. Karen S. Aboody, M.D., associate professor in City of Hope's Department of Neurosciences, leads the research team that developed this treatment strategy. Jana Portnow, M.D., assistant professor and assistant director of the Brain Tumor Program at City of Hope, is the principal investigator for the clinical trial.

9 Jun 2010

VARI researchers identify enzyme that could help diagnose and treat cholangiocarcinoma

In collaboration with the National Cancer Centre, Singapore, Van Andel Research Institute researchers have identified an enzyme that could help diagnose and treat cholangiocarcinoma, a form of liver cancer that strikes up to 3,000 new patients each year in the United States.

9 Jun 2010

Psychological intervention program teaches breast cancer patients how to cope with the disease

A psychological intervention program designed for breast cancer patients reduces the risk of dying if the cancer recurs, new research shows. The study is the latest in a series at Ohio State University that have shown that an intervention program that teaches patients how to cope with the disease can boost their health, well-being and even their chances of survival.

9 Jun 2010

In the news: Senate and jobs bill; Obama appeals to seniors; States' Medicaid squeeze; Beyond COBRA

Today's headlines highlights President Obama's planned visit to a senior center to tout health reform, while several columns examine insurance issues, what doctors say about electronic medical record goals and military treatment of traumatic brain injuries is investigated.

9 Jun 2010

Researchers find LEB or EV demonstrates faster rate of healing for larger wounds

Researchers from Georgetown University Hospital in Washington, DC have found that wound healing after lower extremity bypass or endovascular revascularization demonstrated a more complete and faster rate of healing for larger wounds of more than 2 cm after open bypass. Findings will be presented at the 64th Vascular Annual Meeting presented by the Society for Vascular Surgery, June 10 in Boston.

8 Jun 2010

Phase 2 study results of Qnexa in patients with OSA presented at SLEEP 2010

VIVUS, Inc. today announced that data from a previously reported phase 2 study evaluating the safety and efficacy of the investigational drug Qnexa for the treatment of obstructive sleep apnea were presented at SLEEP 2010, the 24th Annual Meeting of the Associated Professional Sleep Societies.

8 Jun 2010

FDA grants Cepheid marketing clearance for Xpert SA Nasal Complete molecular test

Cepheid today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® SA Nasal Complete, the first and only molecular test designed for the simultaneous detection and differentiation of both Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) colonization in less than one hour. The test runs on Cepheid's GeneXpert® System, the world's leading molecular platform for accuracy, speed, and ease-of-use.

8 Jun 2010

Combined cardiac bypass and liver tumor surgery performed on 63-year-old Nigerian

Adding another feat to the history of cardiothoracic surgery at Fortis Hospitals Bangalore, the team of experts led by noted Dr. Vivek Jawali, Chief Cardiothoracic Surgeon and Dr. Ramcharan Thiagarajan, Consultant Surgical GI & Hepato-Pancreatic Biliary Surgoen has performed a combined cardiac bypass and liver tumor surgery on a 63 year old Nigerian.

8 Jun 2010

Integra LifeSciences announces over 800 implantations of Vu a-POD fusion device

Integra LifeSciences announced today a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been implanted in over 800 patients in the U.S.

8 Jun 2010

TG-MV-006 study: Microplasmin shows promise for treatment of VMA, MH

A Phase III trial of a drug used for the treatment of vitreomacular adhesion and macular hole revealed key findings for patients diagnosed with these severe conditions which can lead to significant vision impairment.

8 Jun 2010

Top 10 tips to avoid medical mistakes

In this new original and eye-opening book, THE NOT SO PATIENT ADVOCATE: How To Get The Healthcare You Need Without Fear Or Frustration, readers walk through the seemingly forbidden or secretive door to the mystifying and occasionally infuriating maze that is today's healthcare machine. The author shares candid facts about what actually goes on where healthcare interaction occurs.

8 Jun 2010

New technology involving adipose stem cells may one day cure patients with severe wounds: Researchers

New technology developed by University of Virginia inventors involving adipose stem cells - adult stem cells found in fatty tissue - could one day be used to treat patients with severe wounds and other serious conditions.

8 Jun 2010

Single semen test for clearance following vasectomy

Having to provide repeated semen samples following a vasectomy could soon be a thing of the past, after 96 per cent of men were given the all-clear based on a single test three months after surgery.

8 Jun 2010

Researchers compare clinical outcome of patients with smaller and larger AAAs after EVAR

Patients with abdominal aortic aneurysms of less than 5.5 cm have no significant differences in clinical outcomes after endovascular repair than those with larger AAAs according to data from a five-year prospective clinical trial setting. The researchers maintain their recommendation that small aneurysms should not be treated surgically.

8 Jun 2010

New study assesses accuracy of indirect estimated radiation doses during eTAAA

A new study, presented at the 64th Vascular Annual Meeting presented by the Society for Vascular Surgery® today, assessed the accuracy of indirect estimated radiation doses of 47 patients during endovascular thoracoabdominal aneurysm repair (eTAAA).

8 Jun 2010

Surgery News and Research

Patients with BAI can be managed non-operatively with beta-blockade: Researchers

Researchers compare effectiveness of IB and AMP in high-risk patients

Tumors not likely to worsen during active surveillance period in low risk prostate cancer patients

Sonic hedgehog helps regenerate critical nerve that runs along prostate: Research

Preoperative BB usage to help prevent POMI revealed at Vascular Annual Meeting

FDA approves City of Hope's neural stem cell-based therapy study for recurrent high-grade gliomas

VARI researchers identify enzyme that could help diagnose and treat cholangiocarcinoma

Psychological intervention program teaches breast cancer patients how to cope with the disease

In the news: Senate and jobs bill; Obama appeals to seniors; States' Medicaid squeeze; Beyond COBRA

Researchers find LEB or EV demonstrates faster rate of healing for larger wounds

Phase 2 study results of Qnexa in patients with OSA presented at SLEEP 2010

FDA grants Cepheid marketing clearance for Xpert SA Nasal Complete molecular test

Combined cardiac bypass and liver tumor surgery performed on 63-year-old Nigerian

Integra LifeSciences announces over 800 implantations of Vu a-POD fusion device

TG-MV-006 study: Microplasmin shows promise for treatment of VMA, MH

Top 10 tips to avoid medical mistakes

New technology involving adipose stem cells may one day cure patients with severe wounds: Researchers

Single semen test for clearance following vasectomy

Researchers compare clinical outcome of patients with smaller and larger AAAs after EVAR

New study assesses accuracy of indirect estimated radiation doses during eTAAA

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News